Literature DB >> 19787828

Spectrum of anemia associated with chronic liver disease.

Rosario Gonzalez-Casas1, E Anthony Jones, Ricardo Moreno-Otero.   

Abstract

Anemia of diverse etiology is a common complication of chronic liver diseases. The causes of anemia include acute or chronic gastrointestinal hemorrhage, and hypersplenism secondary to portal hypertension. Severe hepatocellular disease predisposes to hemorrhage because of impaired blood coagulation caused by deficiency of blood coagulation factors synthesized by hepatocytes, and/or thrombocytopenia. Aplastic anemia, which is characterized by pancytopenia and hypocellular bone marrow, may follow the development of hepatitis. Its presentation includes progressive anemia and hemorrhagic manifestations. Hematological complications of combination therapy for chronic viral hepatitis include clinically significant anemia, secondary to treatment with ribavirin and/or interferon. Ribavirin-induced hemolysis can be reversed by reducing the dose of the drug or discontinuing it altogether. Interferons may contribute to anemia by inducing bone marrow suppression. Alcohol ingestion is implicated in the pathogenesis of chronic liver disease and may contribute to associated anemia. In patients with chronic liver disease, anemia may be exacerbated by deficiency of folic acid and/or vitamin B12 that can occur secondary to inadequate dietary intake or malabsorption.

Entities:  

Mesh:

Year:  2009        PMID: 19787828      PMCID: PMC2754513          DOI: 10.3748/wjg.15.4653

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

Review 1.  Prevention of recurrent esophageal variceal hemorrhage: review and current recommendations.

Authors:  David Kravetz
Journal:  J Clin Gastroenterol       Date:  2007 Nov-Dec       Impact factor: 3.062

2.  Factors influencing ribavirin-induced hemolysis.

Authors:  H Van Vlierbergh; J R Delanghe; M De Vos; G Leroux-Roel
Journal:  J Hepatol       Date:  2001-06       Impact factor: 25.083

Review 3.  Coagulation disorders in liver disease.

Authors:  Lucio Amitrano; Maria A Guardascione; Vincenzo Brancaccio; Antonio Balzano
Journal:  Semin Liver Dis       Date:  2002-02       Impact factor: 6.115

4.  Immune-mediated hepatitis-associated aplastic anemia caused by the emergence of a mutant hepatitis B virus undetectable by standard assays.

Authors:  Elisabetta Cariani; Anna Maria Pelizzari; Anna Rodella; Franco Gargiulo; Luisa Imberti; Nino Manca; Giuseppe Rossi
Journal:  J Hepatol       Date:  2007-01-26       Impact factor: 25.083

Review 5.  Thrombocytopenia associated with chronic liver disease.

Authors:  Nezam Afdhal; John McHutchison; Robert Brown; Ira Jacobson; Michael Manns; Fred Poordad; Babette Weksler; Rafael Esteban
Journal:  J Hepatol       Date:  2008-03-31       Impact factor: 25.083

Review 6.  Preventing first variceal hemorrhage in cirrhosis.

Authors:  Agustín Albillos
Journal:  J Clin Gastroenterol       Date:  2007 Nov-Dec       Impact factor: 3.062

Review 7.  The treatment of acute variceal bleeding.

Authors:  Juan G Abraldes; Jaime Bosch
Journal:  J Clin Gastroenterol       Date:  2007 Nov-Dec       Impact factor: 3.062

Review 8.  Systematic review: hepatitis-associated aplastic anaemia--a syndrome associated with abnormal immunological function.

Authors:  R Gonzalez-Casas; L Garcia-Buey; E A Jones; J P Gisbert; R Moreno-Otero
Journal:  Aliment Pharmacol Ther       Date:  2009-06-09       Impact factor: 8.171

Review 9.  Review article: the modern management of portal hypertension--primary and secondary prophylaxis of variceal bleeding in cirrhotic patients.

Authors:  J C Garcia-Pagan; A De Gottardi; J Bosch
Journal:  Aliment Pharmacol Ther       Date:  2008-05-02       Impact factor: 8.171

Review 10.  Aplastic anemia.

Authors:  Neal S Young; Phillip Scheinberg; Rodrigo T Calado
Journal:  Curr Opin Hematol       Date:  2008-05       Impact factor: 3.284

View more
  45 in total

1.  Relationship between splenomegaly and transfusion requirements in patients with cirrhosis.

Authors:  Christopher H Tan; James A Hall; Kendall Hammonds; Jyothi Dodlapati; Walter J Linz; Sherronda M Henderson
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-09-02

2.  The Impact of Preoperative Hemoglobin Level on the Short-Term Outcomes After Living Donor Liver Transplantation.

Authors:  Amr Badawy; Toshimi Kaido; Ahmed Hammad; Shintaro Yagi; Naoko Kamo; Atsushi Yoshizawa; Hideaki Okajima; Shinji Uemoto
Journal:  World J Surg       Date:  2018-12       Impact factor: 3.352

3.  Alteration of micronutrient status in compensated and decompensated liver cirrhosis.

Authors:  Kaushik Kar; Anindya Dasgupta; M Vijaya Bhaskar; K Sudhakar
Journal:  Indian J Clin Biochem       Date:  2013-06-14

4.  Hepatitis-associated aplastic anaemia: a poor prognosis.

Authors:  Vivian Gonçalves; Rita Calado; Maria João Palaré; Anabela Ferrão; Anabela Morais
Journal:  BMJ Case Rep       Date:  2013-02-13

Review 5.  Patient Blood Management: a revolutionary approach to transfusion medicine.

Authors:  Massimo Franchini; Giuseppe Marano; Eva Veropalumbo; Francesca Masiello; Ilaria Pati; Fabio Candura; Samantha Profili; Liviana Catalano; Vanessa Piccinini; Simonetta Pupella; Stefania Vaglio; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2019-05       Impact factor: 3.443

6.  Hepatic involvement in pediatric patients with paracoccidioidomycosis: a clinical and laboratory study.

Authors:  Giselle de Melo Braga; Gabriel Hessel; Ricardo Mendes Pereira
Journal:  Mycopathologia       Date:  2013-08-06       Impact factor: 2.574

7.  High-dose steroids as a therapeutic option in the management of spur cell haemolytic anaemia.

Authors:  Dhauna Karam; Sean Swiatkowski; Pant Purohit; Bharat Agrawal
Journal:  BMJ Case Rep       Date:  2018-01-31

Review 8.  Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma.

Authors:  Bruno Sangro; Stephen L Chan; Tim Meyer; María Reig; Anthony El-Khoueiry; Peter R Galle
Journal:  J Hepatol       Date:  2020-02       Impact factor: 25.083

9.  Bone marrow dyspoiesis associated with severe refractory anaemia in liver cirrhosis.

Authors:  Annapoorani Varadarajan; Deepika Lal; Radhika Kapil; Chhagan Bihari
Journal:  Frontline Gastroenterol       Date:  2020-02-04

10.  A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study.

Authors:  Giovanni Marasco; Francesco Poggioli; Antonio Colecchia; Giuseppe Cabibbo; Filippo Pelizzaro; Edoardo Giovanni Giannini; Sara Marinelli; Gian Ludovico Rapaccini; Eugenio Caturelli; Mariella Di Marco; Elisabetta Biasini; Fabio Marra; Filomena Morisco; Francesco Giuseppe Foschi; Marco Zoli; Antonio Gasbarrini; Gianluca Svegliati Baroni; Alberto Masotto; Rodolfo Sacco; Giovanni Raimondo; Francesco Azzaroli; Andrea Mega; Gianpaolo Vidili; Maurizia Rossana Brunetto; Gerardo Nardone; Luigina Vanessa Alemanni; Elton Dajti; Federico Ravaioli; Davide Festi; Franco Trevisani; On Behalf Of The Italian Liver Cancer Ita Li Ca Group
Journal:  Cancers (Basel)       Date:  2021-05-29       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.